PKM and hepatocellular carcinoma: Inhibition of miR-18b-5p, enhancement of PKM expression, activation of the HIF-1α-dependent glycolytic pathway, promotion of proliferation, migration and invasion of HCC cells, and promotion of M2-type polarization in tumor-associated macrophages